These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7549077)

  • 21. Late potentials on signal-averaged electrocardiograms and patency of the infarct-related artery in survivors of acute myocardial infarction.
    Vatterott PJ; Hammill SC; Bailey KR; Wiltgen CM; Gersh BJ
    J Am Coll Cardiol; 1991 Feb; 17(2):330-7. PubMed ID: 1899434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of streptokinase, but not tissue-type plasminogen activator, in achieving 90-minute patency after thrombolysis for acute myocardial infarction decreases with time to treatment. PERM Study Group. Prospective Evaluation of Reperfusion Markers.
    Steg PG; Laperche T; Golmard JL; Juliard JM; Benamer H; Himbert D; Aubry P
    J Am Coll Cardiol; 1998 Mar; 31(4):776-9. PubMed ID: 9525545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of early accelerated dose tissue plasminogen activator on in-hospital patency of the infarcted vessel in patients with acute right ventricular infarction.
    Giannitsis E; Potratz J; Wiegand U; Stierle U; Djonlagic H; Sheikhzadeh A
    Heart; 1997 Jun; 77(6):512-6. PubMed ID: 9227293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma N-terminal fragment of the prohormone B-type natriuretic peptide concentrations in relation to time to treatment and Thrombolysis in Myocardial Infarction (TIMI) flow: a substudy of the Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT IV-PCI) trial.
    Jarai R; Huber K; Bogaerts K; Droogne W; Ezekowitz J; Granger CB; Sinnaeve PR; Ross AM; Zeymer U; Armstrong PW; Van de Werf FJ;
    Am Heart J; 2010 Jan; 159(1):131-40. PubMed ID: 20102879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute myocardial infarction: the case for pre-hospital thrombolysis with or without percutaneous coronary intervention.
    Schofield PM
    Heart; 2005 Jun; 91 Suppl 3(Suppl 3):iii7-11. PubMed ID: 15919654
    [No Abstract]   [Full Text] [Related]  

  • 26. Usefulness of late coronary thrombolysis (recombinant tissue-type plasminogen activator) in preserving left ventricular function in acute myocardial infarction.
    Villari B; Piscione F; Bonaduce D; Golino P; Lanzillo T; Condorelli M; Chiariello M
    Am J Cardiol; 1990 Dec; 66(19):1281-6. PubMed ID: 2123072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accelerated plasminogen activator dose regimens for coronary thrombolysis. The TAMI-7 Study Group.
    Wall TC; Califf RM; George BS; Ellis SG; Samaha JK; Kereiakes DJ; Worley SJ; Sigmon K; Topol EJ
    J Am Coll Cardiol; 1992 Mar; 19(3):482-9. PubMed ID: 1537998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized trial of recombinant staphylokinase versus alteplase for coronary artery patency in acute myocardial infarction. The STAR Trial Group.
    Vanderschueren S; Barrios L; Kerdsinchai P; Van den Heuvel P; Hermans L; Vrolix M; De Man F; Benit E; Muyldermans L; Collen D
    Circulation; 1995 Oct; 92(8):2044-9. PubMed ID: 7554180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Independent impact of thrombolytic therapy and vessel patency on left ventricular dilation after myocardial infarction. Serial echocardiographic follow-up.
    Popović AD; Nesković AN; Babić R; Obradović V; Bozinović L; Marinković J; Lee JC; Tan M; Thomas JD
    Circulation; 1994 Aug; 90(2):800-7. PubMed ID: 8044951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immediate coronary angioplasty versus intravenous streptokinase in acute myocardial infarction: left ventricular ejection fraction, hospital mortality and reinfarction.
    de Boer MJ; Hoorntje JC; Ottervanger JP; Reiffers S; Suryapranata H; Zijlstra F
    J Am Coll Cardiol; 1994 Apr; 23(5):1004-8. PubMed ID: 8144761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pivotal role of early and sustained infarct vessel patency in patients with acute myocardial infarction.
    Topol EJ; Wilson VE
    Heart Lung; 1990 Nov; 19(6):583-93. PubMed ID: 2228647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombolysis and coronary occlusion: effects upon the non-infarct zone.
    Cranswick R; Carter G; Wilkes N; Nelson G
    Eur Heart J; 1992 Jun; 13(6):770-5. PubMed ID: 1623865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI-1) trial: influence of infarct location on arterial patency, left ventricular function and mortality.
    Bates ER; Califf RM; Stack RS; Aronson L; George BS; Candela RJ; Kereiakes DJ; Abbottsmith CW; Anderson L; Pitt B
    J Am Coll Cardiol; 1989 Jan; 13(1):12-8. PubMed ID: 2521226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience.
    Woodfield SL; Lundergan CF; Reiner JS; Greenhouse SW; Thompson MA; Rohrbeck SC; Deychak Y; Simoons ML; Califf RM; Topol EJ; Ross AM
    J Am Coll Cardiol; 1996 Dec; 28(7):1661-9. PubMed ID: 8962549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is survival in acute myocardial infarction related to thrombolytic efficacy or the open-artery hypothesis? A controversy to be investigated with GUSTO.
    Bates ER
    Chest; 1992 Apr; 101(4 Suppl):140S-150S. PubMed ID: 1555479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of time to treatment on early infarct-related artery patency after different thrombolytic regimens. ALKK-Study Group.
    Zeymer U; Tebbe U; Essen Rv; Haarmann W; Neuhaus KL
    Am Heart J; 1999 Jan; 137(1):34-8. PubMed ID: 9878934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High dose bolus heparin as initial therapy before primary angioplasty for acute myocardial infarction: results of the Heparin in Early Patency (HEAP) pilot study.
    Verheugt FW; Liem A; Zijlstra F; Marsh RC; Veen G; Bronzwaer JG
    J Am Coll Cardiol; 1998 Feb; 31(2):289-93. PubMed ID: 9462569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Case report. Thrombolytic therapy 17 hours after acute myocardial infarct: assessing myocardial viability with 201 thallium imaging].
    Lund GK; Koschyk DH; Nienaber CA
    Herz; 1994 Feb; 19(1):65-8. PubMed ID: 8150415
    [No Abstract]   [Full Text] [Related]  

  • 39. Coronary bypass surgery improves global and regional left ventricular function following thrombolytic therapy for acute myocardial infarction. TAMI Study Group.
    Kereiakes DJ; Califf RM; George BS; Ellis S; Samaha J; Stack R; Martin LH; Young S; Topol EJ
    Am Heart J; 1991 Aug; 122(2):390-9. PubMed ID: 1907087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced myocardial salvage by maintenance of microvascular patency following initial thrombolysis with recombinant tissue plasminogen activator.
    Longridge DJ; Follenfant MJ; Maxwell MP; Ford AJ; Hughes B
    Cardiovasc Res; 1990 Sep; 24(9):697-706. PubMed ID: 2121357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.